REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Npp Tehnogen OOO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Npp Tehnogen OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Nauchno-Proizvodstvennoe Predpriyatie Tehnogen OOO is a pharmaceutical company. It specializes in developing and producing medical and biological preparations, with a focus on manufacturing Hemaza, a fibrinolytic remedy for ophthalmology. The medication is effective in treating various eye conditions and is used in ophthalmology for different therapeutic purposes.

Headquarters
Cherepkovskaya 3-Ya, 15A, 7
Moscow; Moscow; Postal Code: 121552

Contact Details: Purchase the Npp Tehnogen OOO report to view the information.

Website: http://gemaza.ru

Basic Information
Total Employees:
Purchase the Npp Tehnogen OOO report to view the information.
Outstanding Shares:
Purchase the Npp Tehnogen OOO report to view the information.
Registered Capital:
Purchase the Npp Tehnogen OOO report to view the information.
Incorporation Date:
November 19, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
22.3%
Purchase this report to view the information.
22.2%
Purchase this report to view the information.
22.2%
Purchase this report to view the information.
11.1%
Purchase this report to view the information.
11.1%
Subsidiaries
Associaciya Azt AO
1.9%
Company Performance
Financial values in the chart are available after Npp Tehnogen OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
39.78%▲
Total operating revenue
39.78%▲
Operating profit (EBIT)
257.37%▲
Net Profit (Loss) for the Period
87.87%▲
Total assets
-5.27%▼
Total equity
-0.97%▼
Operating Profit Margin (ROS)
4.64%▲
Net Profit Margin
28.95%▲
Return on Equity (ROE)
7.05%▲
Debt to Equity Ratio
-0.18%▼
Quick Ratio
22.5%▲
Cash Ratio
13.28%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo